A groundbreaking blood test can significantly accelerate the detection of more than 50 types of cancer. This is evident from an American study, the results of which were presented at the European Society for Medical Oncology (ESMO) conference in Berlin. In almost 62 percent of the cases, the prediction was correct at a (very) early stage.

ttn-3